TABLE 2.
Species | MIC (μg/ml)a
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CL | CM | EM | GM | KM | RIF | SM | TO | SU | TC | MC | TP | |
L. monocytogenes | >2 | 8–>16 | 8 | >8 | 64–>256 | 32–64 | 32–64 | 8 | >1,024 | 64–128 | >4 | 1,024 |
64 | >32 | 256 | 8 | |||||||||
2,048 | ||||||||||||
L. innocua | —b | 64–>256 | 64 | — | 128 | >1,024 | 64–>256 | 4–32 | — | |||
512 | ||||||||||||
L. welshimeri | — | — | — | — | — | — | 128 | 4–16 | — |
CL, clindamycin; CM, chloramphenicol; EM, erythromycin; GM, gentamicin; KM, kanamycin; MC, minocycline; RIF, rifampin; SM, streptomycin; SU, sulfonamide; TO, tobramycin; TC, tetracycline; TP, trimethoprim.
—, no resistance.